Simultaneous quantitative analysis of three drugs by high‐performance liquid chromatography/electrospray ionization mass spectrometry and its application to cassette in vitro metabolic stability studies
- 7 August 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (18) , 2063-2070
- https://doi.org/10.1002/rcm.1151
Abstract
A sensitive and selective liquid chromatography/electrospray mass spectrometry (LC/ESI‐MS) method has been developed for the simultaneous quantitative determination of three new chemical entities (NCEs), of the class of aryloxy‐substituted aryl piperazines, in rat liver S9 fraction. S9 fraction samples (0.1 mL) were simply extracted with 2% isopropanol in diethyl ether and the extracts analyzed by HPLC with the detection of the analytes in the selective ion recording (SIR) mode. The determination of the analytes was accurate and reproducible, with a limit of quantification of 50 ng/mL for all the analytes in rat liver S9 fraction. The standard calibration curve for the analytes was linear over the concentration range 50–4000 ng/mL. Analysis accuracy and precision over the concentration range were lower than ±15%. This method offered significant increase in the analytical throughput, which is illustrated by the ‘N‐in‐One’ study of metabolic stability of the compounds in rat liver S9 fractions. The quantitative results from the ‘N‐in‐One’ procedure correlated well with those obtained from conventional discrete analyses. In addition, the samples were reanalyzed to allow for detection of the metabolites formed during the same incubation. The metabolites were first characterized by nominal mass measurement of the corresponding protonated molecules. Subsequent tandem mass spectrometry allowed confirmation of the detected metabolites. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2002
- LC fluorescence method for multiple synthetic compounds to rapidly create in vivo pharmacokinetic database utilizing ‘N-in-One’ dosingJournal of Pharmaceutical and Biomedical Analysis, 2001
- High-throughput screening approaches for investigating drug metabolism and pharmacokineticsXenobiotica, 2001
- In-vitro Biotransformation of BOF-4272, a Sulphoxide-containing Drug, in Rats, Mice and Cynomolgus Monkeys: Sex and Species DifferencesPharmacy and Pharmacology Communications, 1999
- Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stabilityRapid Communications in Mass Spectrometry, 1999
- Sample pooling to expedite bioanalysis and pharmacokinetic researchJournal of Pharmaceutical and Biomedical Analysis, 1998
- Simultaneous Pharmacokinetic Screening of a Mixture of Compounds in the Dog Using API LC/MS/MS Analysis for Increased ThroughputJournal of Medicinal Chemistry, 1997
- The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as anIn Vivo Drug Screening ProcedureRapid Communications in Mass Spectrometry, 1997
- Lead development: Validation and application of high throughput screening for determination of pharmacokinetic parameters for enzyme inhibitorsBioorganic & Medicinal Chemistry, 1996
- Use of in vitro human metabolism studies in drug developmentBiochemical Pharmacology, 1994